Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

FNEFA
91135
MGRNA
61646
Clinical References: Natural Killer (NK) Cytotoxicity Profile: Patarca R, Fletcher MA, Podack ER:
Chapter 33: Cytolytic cell functions. In Manual of Clinical Laboratory Immunology. Fifth edition. Edited
by NR Rose, E Conway de Macario, JD Folds, et all. Washington, DC, ASM Press, 1997 T- and B-Cell
Quantitation by Flow Cytometry: 1. Carmichael KF, Abayomi A: Analysis of diurnal variation of
lymphocyte subsets in healthy subjects and its implication in HIV monitoring and treatment. 15th Intl
Conference on AIDS, Bangkok, Thailand, 2004, Abstract B11052 2. Dimitrov S, Benedict C, Heutling D,
et al: Cortisol and epinephrine control opposing circadian rhythms in T-cell subsets. Blood 2009
(prepublished online March 17, 2009) 3. Dimitrov S, Lange T, Nohroudi K, Born J: Number and function
of circulating antigen presenting cells regulated by sleep. Sleep 2007;30:401-411 4. Kronfol Z, Nair M,
Zhang Q, et al: Circadian immune measures in healthy volunteers: relationship to
hypothalamic-pituitary-adrenal axis hormones and sympathetic neurotransmitters. Psychosom Med
1997;59:42-50 5. Malone JL, Simms TE, Gray GC, et al: Sources of variability in repeated T-helper
lymphocyte counts from HIV 1-infected patients: total lymphocyte count fluctuations and diurnal cycle
are important. J AIDS 1990;3:144-151 6. Paglieroni TG, Holland PV: Circannual variation in lymphocyte
subsets, revisited. Transfusion 1994;34:512-516 7. Mandy FF, Nicholson JK, McDougal JS: Guidelines
for performing single-platform absolute CD4+T-cell determinations with CD45 gating for persons
infected with human immunodeficiency virus. Center for Disease Control and Prevention. MMWR Morb
Mortal Wkly Rep 2003;52:1-13 8. Centers for Disease Control: 1997 Revised guidelines for performing
CD4+ T-cell determinations in persons infected with human immunodeficiency virus (HIV). MMWR
Morb Mortal Wkly Rep 46 no. RR-2: 1997, pp 1-29 9. U.S. Department of Health and Human Services:
Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents
infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 43 no. RR-3: 1994, pp
1-21
Nefazodone (Serzone)
Reference Values:
Expected Nefazodone concentrations on recommended daily
dosage regimens:
100 - 4000 ng/mL
Test Performed By
Medtox Laboratories, Inc.
402 W County Road D
St. Paul, MN 55112
Neisseria gonorrhoea, Miscellaneous Sites, by Nucleic Acid
Amplification (GEN-PROBE)
Clinical Information: Gonorrhea is caused by the bacterium Neisseria gonorrhoeae. It is also a very
common sexually transmitted infection (STI), with 301,174 cases of gonorrhea reported to CDC in
2009.(1,2) Many infections in women are asymptomatic and the true prevalence of gonorrhea is likely
much higher than reported. The organism causes genitourinary infections in women and men and may be
associated with dysuria and vaginal, urethral, or rectal discharge. Complications include pelvic
inflammatory disease in women and gonococcal epididymitis and prostatitis in men. Gonococcal
bacteremia, pharyngitis, and arthritis may also occur. Infection in men is typically associated with
symptoms that would prompt clinical evaluation. Given the risk for asymptomatic infection in women,
screening is recommended for women at increased risk of infection (eg, women with previous gonorrhea
or other STI, inconsistent condom use, new or multiple sex partners, and women in certain demographic
groups such as those in communities with high STI prevalence).(1,2) The CDC currently recommends
dual antibiotic treatment due to emerging antimicrobial resistance.(2) Culture was previously considered
to be the gold standard test for diagnosis of Neisseria gonorrhoeae infection. However, organisms are
labile in vitro, and precise specimen collection, transportation, and processing conditions are required to
Current as of January 3, 2013 2:22 pm CST 800-533-1710 or 507-266-5700 or MayoMedicalLaboratories.com Page 1294